Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-05-28

FDA Approved: TIMOLOL GFS — Supplemental Application (Sandoz Inc)

View source ↗

Summary

The FDA approved a supplemental application for TIMOLOL GFS (timolol maleate) submitted by Sandoz Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TIMOLOL GFS (TIMOLOL MALEATE)

Snippet

SUPPL AP for TIMOLOL GFS (TIMOLOL MALEATE)